Silence Therapeutics plc
SLN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001479615
No open-market purchases or sales by Silence Therapeutics plc insiders were filed in the last 90 days; 72 institutions reported holding it in 13F filings for Q2 2026, worth $236.2M in total; no superinvestor holds it.
Other share classesSLNCF
Q2 2024 vs. Q1 2024
How the institutions holding Silence Therapeutics plc changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 64 | 71 | +7 |
| Shares | 27.7M | 27.2M | −496.1K (−1.8%) |
| Value | $588.0M | $502.1M | −$85.9M (−14.6%) |
New holders (12)
Institutions that held Silence Therapeutics plc at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| First Turn Management, LLC | 537,338 | $10.2M | 1.66% |
| Ikarian Capital, LLC | 506,665 | $3.29M | 1.03% |
| Nicholas Investment Partners, LP | 150,480 | $2.86M | 0.30% |
| StemPoint Capital LP | 124,866 | $2.37M | 0.70% |
| New York State Common Retirement Fund | 24,066 | $457.3K | 0.00% |
| Legato Capital Management LLC | 19,800 | $376.2K | 0.05% |
| Y-Intercept (Hong Kong) Ltd | 17,155 | $325.9K | 0.02% |
| Custom Index Systems, LLC | 14,836 | $281.9K | 0.16% |
| Vestcor Inc | 8,800 | $167.0K | 0.01% |
| Quarry LP | 6,000 | $114.0K | 0.05% |
| Royal Bank of Canada | 4,716 | $89.0K | 0.00% |
| Virtus ETF Advisers LLC | 4,591 | $87.2K | 0.04% |
Sold out (5)
Institutions that held Silence Therapeutics plc at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Lombard Odier Asset Management (Europe) Ltd | 2,238,039 | $48.3M |
| Lynx1 Capital Management LP | 526,642 | $11.4M |
| Shay Capital LLC | 15,150 | $327.2K |
| JPMorgan Chase & Co | 9,610 | $207.6K |
| Qube Research & Technologies Ltd | 3,942 | $85.1K |